The World Health Organization (WHO) has published new guidelines for nations on how to mitigate the short-term and long-term consequences of abrupt and drastic cuts to external financing, which are interfering with the provision of critical health se
Cipla Ltd. had signed binding agreements to purchase the entire shareholding of Inzpera Healthscience Pvt. Ltd. for around Rs 110.65 crore.
Novo Nordisk has made public the submission of an unsolicited proposal to Metsera, Inc. acquisition. Metsera is a biotech company with a strong portfolio of both early and development-stage incretin and non-incretin
Health Biotech Limited, an Indian pharma company focused on research, participated successfully at CPHI Frankfurt 2025, a leading global pharmaceutical exhibition, held from October 28 to 30 in Germany.
Dr. Reddy's Laboratories (DRL) will probably take some time to release its generic injectable semaglutide in Canada after receiving the health regulatory body, Health Canada's Pharmaceutical Drugs Directorate, Notice of Non-Compliance (NoN).
The US Food and Drug Administration's (FDA) draft guidance aimed at speeding up and making less expensive biosimilar development is going to be a massive relief to Indian pharma and biotech companies.
German inks and coatings leader Siegwerk has introduced a new range of mineral oil-free inks to India's pharmaceutical packaging sector, thus making a major move towards safer and more compliant packaging solutions.
AskBio, a fully owned and independently operated subsidiary of Bayer AG, has shared positive 12-month data from its Phase 1 clinical trial of AB-1002, an experimental gene therapy for congestive heart failure (CHF).
India has increased its trade protection actions by broadening an anti-dumping probe concerning the import of Ethambutol Hydrochloride, which is a major one of the six essential active pharmaceutical ingredient
Novartis has formally closed its acquisition of Tourmaline Bio, a strategic step to advance its leadership in cardiovascular innovation. After the closing, common stock of Tourmaline, with each share having a par value of $0.0001, has ceased...
.jpg)
, CDSCO.jpg)